DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
600mg Gemcabene ( DrugBank:
Gemcabene
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
265
脂肪萎縮症
1
265. 脂肪萎縮症
臨床試験数
:
112
/
薬物数
:
155
- (
DrugBank
:
55
) /
標的遺伝子数
:
25
-
標的パスウェイ数
:
97
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT03508687
(
ClinicalTrials.gov
)
March 13, 2018
3/4/2018
Study of Gemcabene in Adults With FPLD
An Investigator-Initiated Open-Label, Randomized Study of Gemcabene in Adults With Familial Partial Lipodystrophy Disease (FPLD)
An Investigator-Initiated Open-Label, Randomized Study of Gemcabene in Adults With Familial Partial ...
Familial Partial Lipodystrophy;Hypertriglyceridemia;Fatty Liver;NASH - Nonalcoholic Steatohepatitis
Drug: 300mg Gemcabene;Drug:
600mg Gemcabene
Elif Oral
NULL
Completed
18 Years
N/A
All
5
Phase 1/Phase 2
United States